- Report
- August 2024
- 144 Pages
Global
From €2254EUR$2,500USD£1,955GBP
- Report
- July 2024
- 68 Pages
Global
From €2254EUR$2,500USD£1,955GBP
- Report
- July 2024
- 185 Pages
Global
From €3607EUR$4,000USD£3,128GBP
- Report
- May 2024
- 128 Pages
Global
From €3607EUR$4,000USD£3,128GBP
- Report
- October 2023
- 265 Pages
Global
€4143EUR$4,595USD£3,594GBP
- Report
- June 2025
- 250 Pages
Global
From €4504EUR$4,995USD£3,906GBP
- Report
- January 2025
- 186 Pages
Global
From €4504EUR$4,995USD£3,906GBP
- Report
- July 2024
- 244 Pages
Global
From €4504EUR$4,995USD£3,906GBP
- Report
- May 2025
- 150 Pages
Global
From €4373EUR$4,850USD£3,793GBP
- Report
- May 2025
- 150 Pages
Global
From €4373EUR$4,850USD£3,793GBP
- Report
- January 2024
- 150 Pages
Global
From €4373EUR$4,850USD£3,793GBP
- Report
- June 2023
- 150 Pages
Global
From €4373EUR$4,850USD£3,793GBP
- Report
- May 2026
- 150 Pages
Australia
From €4373EUR$4,850USD£3,793GBP
- Report
- May 2026
- 150 Pages
Brazil
From €4373EUR$4,850USD£3,793GBP
- Report
- May 2026
- 150 Pages
Canada
From €4373EUR$4,850USD£3,793GBP
- Report
- May 2026
- 150 Pages
Germany
From €4373EUR$4,850USD£3,793GBP
- Report
- May 2026
- 150 Pages
India
From €4373EUR$4,850USD£3,793GBP
- Report
- May 2026
- 150 Pages
Indonesia
From €4373EUR$4,850USD£3,793GBP
- Report
- May 2026
- 150 Pages
Italy
From €4373EUR$4,850USD£3,793GBP
- Report
- May 2026
- 150 Pages
Japan
From €4373EUR$4,850USD£3,793GBP

The Inhalers and Nebulisers market is a segment of the medical device industry that focuses on the development and production of devices used to deliver medication to the lungs. Inhalers and nebulisers are used to treat a variety of respiratory conditions, including asthma, COPD, and cystic fibrosis. Inhalers are handheld devices that deliver medication directly to the lungs in the form of a mist or aerosol. Nebulisers are larger devices that use a compressor to convert liquid medication into a mist that can be inhaled.
Inhalers and nebulisers are used by millions of people around the world, and the market is expected to grow in the coming years. Companies in the market include GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novartis, and Teva Pharmaceuticals. These companies are involved in the development and production of inhalers and nebulisers, as well as the research and development of new treatments for respiratory conditions. Show Less Read more